The global compound pharmacy packaging market is growing rapidly and is expected to see a significant increase in revenue from 2025 to 2034. Key players in the market are focusing on mergers and acquisitions to develop advanced technologies for manufacturing compound pharmacy packaging, which will drive the markets growth during this period.
Chief Commercial Marketing & Innovation Officer Carole Grassi Mircich claims that SGD Pharma has a track record of promptly meeting its clients changing pharmaceutical packaging requirements. The expansion of Sterinity range coincides with a boom in the demand for parenteral medications worldwide. For biologics and novel treatments that call for glass vials for parenteral administration, companies handy new 10ml and 20ml ISO molded glass vials in tray offer the best packaging option. SGD Pharma will be at the forefront of the worldwide business by innovating and producing superior primary glass packaging for companies clients and partners.
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com